Affluent Medical S.A. (AFME.PA) Stock
Affluent Medical S.A., a French enterprise, specializes in the creation of minimally invasive medical solutions designed to address cardiovascular and vascular conditions. Its product pipeline includes the Kardiozis technology, engineered to manage abdominal aortic aneurysms, alongside the Kalios and Epygon implants, which target mitral insufficiency.
Valuation
Financials & Margins
Latest News
Valuation & Return Ratios
Peer Comparison
About Affluent Medical S.A.
Affluent Medical S.A., a French enterprise, specializes in the creation of minimally invasive medical solutions designed to address cardiovascular and vascular conditions. Its product pipeline includes the Kardiozis technology, engineered to manage abdominal aortic aneurysms, alongside the Kalios and Epygon implants, which target mitral insufficiency. Additionally, the company offers the Artus implant, an advanced electromechanical artificial sphincter devised for the comprehensive treatment of severe urinary incontinence in both female and male patients. Established in 2011, its headquarters are situated in Aix-en-Provence, France.
Affluent Medical S.A. is led by CEO Sebastien Ladet, employs 66 people, headquartered in Aix-en-Provence, FR, publicly traded since 2021.
Official website: www.carvolix.eu